UC-CARE

As of January 1, 2026, the long-standing prostate biopsy billing code CPT® 55700 has been retired by the American Medical Association and replaced with a more detailed set of procedure-specific CPT® codes. These updates distinguish prostate biopsy procedures by approach, imaging guidance, and whether MRI-identified lesions are targeted. The update reflects current prostate cancer biopsy practice, where MRI–ultrasound fusion biopsy plays an increasingly important role in detec

Current Procedural Terminology (CPT®) codes, developed and maintained by the American Medical Association (AMA), are updated annually to reflect changes in medical science, technology, and practice – ensuring billing and reimbursement accuracy, relevance, and alignment with modern care. CPT code 55700, the current standard for all types of prostate biopsy procedures, will be terminated starting January 1, 2026, to reflect significant advancements in the diagnosis of prostate

Focal therapy is a relatively recent addition to physician's toolkits to safely and effectively treat prostate cancer. It offers patients...

For hospitals, the Navigo 4D Fusion Navigation System is not just important for providing access to a gold standard of care — it's a...